OXIGENE, INC. FORM 10-Q

Company

Oncotelic Therapeutics, Inc.

Filed

August 8, 2008

Period of Report

June 30, 2008

Accession Number

0000950135-08-005472

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →